首页> 外文期刊>Emerging Infectious Diseases >Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome (http://wwwnc.cdc.gov/eid/article/21/2/13-1879)
【24h】

Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome (http://wwwnc.cdc.gov/eid/article/21/2/13-1879)

机译:流行性感冒和流感疫苗接种对获得格林-巴利综合征风险的模拟研究(http://wwwnc.cdc.gov/eid/article/21/2/13-1879)

获取原文
           

摘要

It is unclear whether seasonal influenza vaccination results in a net increase or decrease in the risk for Guillain-Barré syndrome (GBS). To assess the effect of seasonal influenza vaccination on the absolute risk of acquiring GBS, we used simulation models and published estimates of age- and sex-specific risks for GBS, influenza incidence, and vaccine effectiveness. For a hypothetical 45-year-old woman and 75-year-old man, excess GBS risk for influenza vaccination versus no vaccination was ?0.36/1 million vaccinations (95% credible interval ?1.22 to 0.28) and ?0.42/1 million vaccinations (95% credible interval, –3.68 to 2.44), respectively. These numbers represent a small absolute reduction in GBS risk with vaccination. Under typical conditions (e.g. influenza incidence rates >5% and vaccine effectiveness >60%), vaccination reduced GBS risk. These findings should strengthen confidence in the safety of influenza vaccine and allow health professionals to better put GBS risk in context when discussing influenza vaccination with patients.
机译:目前尚不清楚季节性流感疫苗接种是否会导致格林-巴利综合征(GBS)风险的净增加或减少。为了评估季节性流感疫苗接种对获得GBS绝对风险的影响,我们使用了模拟模型并发布了针对GBS,流感发生率和疫苗有效性的年龄和性别特定风险的估计值。对于假设的45岁女性和75岁男性,GBS接种流感疫苗与未接种疫苗的风险分别为0.36 / 1百万接种(95%可信区间为1.22至0.28)和0.42 / 1百万接种(可信区间为95%,从–3.68到2.44)。这些数字表明,接种疫苗后GBS风险绝对降低了一点。在典型情况下(例如,流感发病率> 5%,疫苗有效性> 60%),接种疫苗可降低GBS风险。这些发现将增强人们对流感疫苗安全性的信心,并使卫生专业人员在与患者讨论流感疫苗接种时可以更好地将GBS风险置于背景之中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号